Increased bruising with the combination of long-chain omega-3 fatty acids,flaxseed oil and clopidogrel

Natural Health Products Directorate—Health Canada. Natural health product tracking survey—2010 final report. Ipsos-Reid; 2011 Jan. Available: http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf (accessed Feb. 23, 2012).

Kelly JP Kaufman DW Kelley K . Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-6.

Berger E . Berger Population Health Monitor: Pharmacy medication and consumer health products report. Survey 2. Toronto (ON): The Hay Health Care Consulting Group; 2002.

Roy-Byrne PP Bystritsky A Russo J . Use of herbal medicine in primary care patients with mood and anxiety disorders. Psychosomatics 2005;46:117-22.

Quandt SA Chen H Grzywacz JG . Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. Arthritis Rheum 2005;53:748-55.

Wood MJ Stewart RL Merry H . Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003;145:806-12.

León H Shibata MC Sivakumaran S . Effect of fish oil on arrhythmias and mortality: systematic review. BMJ 2009;338:a2931.

Anderson BM Ma DW . Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis 2009;8:33.

Calder PC . n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci (Lond) 2004;107:1-11.

Cohen MG Rossi JS Garbarino J . Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel. Thromb Res 2011;128:335-40.

Gajos G Zalewski J Rostoff P . Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI Clot). Arterioscler Thromb Vasc Biol 2011;31:1696-702.

Gajos G Rostoff P Undas A Piwowarska W . Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI study. J Am Coll Cardiol 2010;55:1671-8.

Watson PD Joy PS Nkonde C Hessen SE Karalis DG . Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel—versus—aspirin + clopidogrel in patients with cardiovascular disease. Am J Cardiol 2009;104:1052-4.

Cunnane SC Ganguli S Menard C . High α-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 1993;69:443-53.

Leyva DR Zahradka P Ramjiawan B . The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial. Contemp Clin Trials 2011;32:724-30.

Austria JA Richard MN Chahine MN . Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J Am Coll Nutr 2008; 27:214-21.

Kennedy J . Herb and supplement use in the US adult population. Clin Ther 2005;27:1847-58.

Busse JW Heaton G Wu P . Disclosure of natural health product use to primary care physicians: a cross-sectional survey of naturopathic clinic attendees. Mayo Clin Proc 2005;80:616-23.

Tiralongo E Braun L Wilkinson JM . Exploring the integration of complementary medicines into Australian pharmacy practice with a focus on different practice settings and background knowledge. J Complement Integr Med 2010;7(1):Article 37.

Barnes J Mills SY Abbot NC . Different standards for reporting ADRs to herbal medicines and conventional OTC medicines: face-to-face interviews with 515 users of herbal medicines. Br J Clin Pharmacol 1998;45:496-500.

Vickers KA Jolly KB Greenfield SM . Herbal medicine: women’s views, knowledge and interaction with doctors: a qualitative study. BMC Altern Med 2006;6:40.